ACADIA Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
ACADIA Pharmaceuticals has a total shareholder equity of $395.8M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $642.8M and $247.0M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$375.38m |
| Equity | US$395.79m |
| Total liabilities | US$246.98m |
| Total assets | US$642.77m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ACAD *'s short term assets ($492.6M) exceed its short term liabilities ($187.9M).
Long Term Liabilities: ACAD *'s short term assets ($492.6M) exceed its long term liabilities ($59.0M).
Debt to Equity History and Analysis
Debt Level: ACAD * is debt free.
Reducing Debt: ACAD * has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ACAD * has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if ACAD * has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.